Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Front Immunol. 2017 Dec 22;8:1884. doi: 10.3389/fimmu.2017.01884. eCollection 2017.
Front Immunol. 2017.
PMID: 29375556
Free PMC article.
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.
Launay O, Ndiaye AGW, Conti V, Loulergue P, Sciré AS, Landre AM, Ferruzzi P, Nedjaai N, Schütte LD, Auerbach J, Marchetti E, Saul A, Martin LB, Podda A.
Launay O, et al. Among authors: ndiaye agw.
Front Immunol. 2019 Mar 8;10:335. doi: 10.3389/fimmu.2019.00335. eCollection 2019.
Front Immunol. 2019.
PMID: 30906291
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
Frenck RW Jr, Conti V, Ferruzzi P, Ndiaye AGW, Parker S, McNeal MM, Dickey M, Granada JP, Cilio GL, De Ryck I, Necchi F, Suvarnapunya AE, Rossi O, Acquaviva A, Chandrasekaran L, Clarkson KA, Auerbach J, Marchetti E, Kaminski RW, Micoli F, Rappuoli R, Saul A, Martin LB, Podda A.
Frenck RW Jr, et al. Among authors: ndiaye agw.
EClinicalMedicine. 2021 Aug 13;39:101076. doi: 10.1016/j.eclinm.2021.101076. eCollection 2021 Sep.
EClinicalMedicine. 2021.
PMID: 34430837
Free PMC article.
Item in Clipboard
GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
De Ryck I, Sarakinou E, Nakakana U, Cilio GL, Ndiaye A, Vella V, Auerbach J, Granada JP, Conti V, Podda A.
De Ryck I, et al.
Infect Dis Ther. 2022 Apr;11(2):757-770. doi: 10.1007/s40121-022-00596-x. Epub 2022 Feb 3.
Infect Dis Ther. 2022.
PMID: 35118580
Free PMC article.
Item in Clipboard
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
De Ryck I, Sarakinou E, Nakakana U, Cilio GL, Ndiaye A, Vella V, Auerbach J, Granada JP, Conti V, Podda A.
De Ryck I, et al.
Infect Dis Ther. 2022 Jun;11(3):1313. doi: 10.1007/s40121-022-00634-8.
Infect Dis Ther. 2022.
PMID: 35435576
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite